PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsAtrial fibrillation
MeSH D001281 - atrial fibrillation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001145:Cardiac arrhythmias
144 Companies
29 Drugs
$
Success rate
D001281: 
Atrial fibrillation
133 Companies
26 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyQuinidine Quinidine  1982-01-01   
Abbott BiotherapeuticsWarfarin Panwarfin  1982-01-01   
AbbVieVerapamil, Trandolapril Tarka  1996-10-22   
Able LaboratoriesAtenolol Atenolol  2004-07-30   
Accord HealthcareDiltiazem Diltiazem  2020-04-28   
Dofetilide Dofetilide  2020-06-19   
Metoprolol Metoprolol  2022-10-18   
Rivaroxaban Rivaroxaban Accord  2020-11-16   
ACIC PharmaceuticalsVerapamil Verapamil  2022-03-17   
Alembic PharmaceuticalsMetoprolol Metoprolol  2013-05-28   
Hydrochlorothiazide, Metoprolol Metoprolol Hydrochlorothiazide  2013-11-06   
Alkem LaboratoriesMetoprolol Metoprolol  2020-11-25   
AllerganDiltiazem Dilacor  1992-05-29   
Atenolol Atenolol  1991-12-27   
Atenolol, Chlorthalidone Atenolol Chlorthalidone  1992-07-02   
Diltiazem Cartia  1998-07-09   
Dextromethorphan, Quinidine Dextromethorphan Quinidine  2017-10-10   
Diltiazem Diltiazem  1997-10-10   
Disopyramide Disopyramide  1986-02-02   
Metoprolol Metoprolol  1993-12-21   
Procainamide Procainamide  1982-01-01   
Propafenone Propafenone  2000-10-24   
Quinidine Quinatime  1982-01-01   
Quinidine Quinidine  1982-01-01   
Sotalol Sotalol  2000-07-13   
Diltiazem Taztia  2003-04-10   
Verapamil Verapamil  1986-09-24   
Warfarin Warfarin  1982-08-17   
AltaThera PharmaceuticalsSotalol Sotalol 2038-08-14 2009-07-02   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
90%
18/20
Phase 2
57%
40/70
Phase 3
71%
71/100
Approved: 25Overall Success rate: 37%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Warfarin,
Salicylic acid,
Dabigatran,
Antithrombin iii,
Vitamin k,
Serine,
Sodium chloride,
Sodium lactate,
Microcrystalline cellulose,
Retinol
1
2
3
4
5
6
...
9
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use